Skip to main content
. 2013 May 23;41(6):216–222. doi: 10.5152/TJAR.2013.37

Table 4.

Data regarding the recovery period of the study and control patients (n=123)

Data regarding recovery period Study Group (n=63)
n
% Control Group (n=60)
n
% P
Complications
 Present 22 34,92 18 30,00 0,560*
 Absent 41 65,08 42 70,00
Developing Complications***
 Respiratory distress 17 77,28 12 66,67 0,288*
 Pain 1 4,54 2 11,11
 Hypotension 1 4,54 2 11,11
 Nausea and vomiting 3 13,64 2 11,11
Time to treatment of complications (minutes)
 Untreated 0 0 11 61,12 <0,001*
 0–10 min 21 95,45 4 22,22
 11 min and above 1 4,55 3 16,66
Treatments administered to the complications
 Interventions for respiration 14 63,63 2 28,57 0,202*
 Drug+fluid therapy 4 18,19 3 42,86
 Drug therapy+positioning 2 9,09 2 28,57
 Examination request**** 2 9,09 0 0
Recovery duration (minute) 52,46±17,95*****
Range: 25–95
45,33±17,12*****
Range: 30–110
0,026**
*

Chi-square- test,

**

Independent samples t test

***

The percentage was calculated on the basis of the number of patients developing complications.

****

Chest x-ray, arterial blood gas

*****

Mean, standard deviation